Council bosses will reconsider their decision to move a library after concerns were raised over transparency of a ...

The settlement, announced on Wednesday, resolves 93% of all Zantac cases in state courts against GlaxoSmithKline.

In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a ...

GlaxoSmithKline Pharma is shifting focus to specialty treatments and preventive healthcare, emphasizing adult vaccines and ...

In a report released today, Rajan Sharma from Goldman Sachs maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a ...

UK pharmaceutical giant GSK says it will pay as much as $2.2bn (£1.68bn) to settle thousands of cases in US courts over ...

City AM columnist Mark Kleinman tackles Rachel Reeves' budget plans, M&A and the investment summit in his weekly column.

London: Pfizer recently achieved a significant legal victory by winning bid in a London court to invalidate two patents held ...

The regulatory clearance for Alembic Pharma's Gujarat facility came without any observations. The USFDA had inspected the ...

The deal settles 80,000 US court cases related to allegations that Zantac was contaminated with a suspected carcinogen.

"Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.